✦ LIBER ✦

Myocardial electrophysiological properties in the presence of an AT1angiotensin II receptor antagonist

✍ Scribed by M. H. Cox; S. J. O; M. Gasparo; R. Mukherjee; K. W. Hewett; F. G. Spinale

Publisher: Springer
Year: 1997
Tongue: English
Weight: 896 KB
Volume: 92
Category: Article
ISSN: 0300-8428
DOI: 10.1007/bf00788630

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro phamacology of MK-996, a new po

In vitro phamacology of MK-996, a new potent and selective angiotensin II (AT1) receptor antagonist

✍ Raymond S. L. Chang; Robert J. Bendesky; Tsing-B. Chen; Kristie A. Faust; Paul J 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 880 KB

Effects of cimetidine on pharmacokinetic

Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist

✍ M. R. Goldberg; M. W. Lo; T. E. Bradstreet; M. A. Ritter; P. Högland 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 512 KB

This was a 2-period randomized, crossover study in 8 healthy males to determine the effects of cimetidine (400 mg q.i.d. for 6 days) on the pharmacokinetics and pharmacodynamic effects of the angiotensin II receptor antagonist, losartan (100 mg). Cimetidine increased the AUC for losartan 18% without

The pharmacokinetics and metabolism of C

The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogs

✍ Mary C. Allen; Mark R. Nocerini; Wesley W. Day 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

166 is an orally active, non-peptide angiotensin II (AII) receptor antagonist developed for the treatment of hypertension and congestive heart failure (CHF). In this study, the intravenous (iv) and oral (po) single dose pharmacokinetics (PK), oral multiple dose PK and P450-mediated metabolism of 16

Model reactions targeted at the synthesi

Model reactions targeted at the synthesis of carbon-14 labeled CI-996, a potent antagonist of angiotensin II receptor (1)

✍ I. Victor Ekhato; Che C. Huang 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 361 KB 👁 1 views

## Abstract A reaction sequence suitable for the preparation of an analog of 2‐propyl‐1‐[2′‐(1H‐tetrazol‐5‐yl)[1,1′‐biphenyl]‐4‐yl]methyl‐4‐[2‐(trifluoroacetyl)‐1H‐pyrrol‐1‐yl]‐1H‐imidazole‐5‐carboxylic acid, with ^14^C at the methylene bridge was developed. The would‐be labeled fragment (12) was d

Angiotensin II AT1 receptor antagonists

Angiotensin II AT1 receptor antagonists inhibit the angiotensin-CRF-AVP axis and are potentially useful for the treatment of stress-related and mood disorders

✍ Juan M. Saavedra; Jaroslav Pavel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Progress in the Understanding of Drug–Re

Progress in the Understanding of Drug–Receptor Interactions, Part 1: Experimental Charge-Density Study of an Angiotensin II Receptor Antagonist (C30H30N6O3S) at T=17 K

✍ Riccardo Destro; Raffaella Soave; Mario Barzaghi; Leonardo Lo Presti 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

## Abstract An experimental study of the electron‐density distribution __ρ__(__**r**__) in an angiotensin II receptor antagonist **1** has been made on the basis of single‐crystal X‐ray diffraction data collected at a low temperature. The crystal structure of **1** consists of infinite ribbons in w